(August 9, 2019, 1:38 PM EDT) -- WASHINGTON, D.C. — A per curiam panel of the Federal Circuit U.S. Court of Appeals on Aug. 7 reversed a New Jersey federal judge’s determination that two patents relating to the painkiller “Vimovo” are valid (Nuvo Pharmaceuticals v. Lupin Ltd., et al., Nos. 17--2487, -2488, Fed. Cir., 2019 U.S. App. LEXIS 23559)....